Pflug Alexander, Lukarska Maria, Resa-Infante Patricia, Reich Stefan, Cusack Stephen
European Molecular Biology Laboratory, Grenoble Outstation, 71 Avenue des Martyrs, CS 90181, 38042 Grenoble Cedex 9, France.
European Molecular Biology Laboratory, Grenoble Outstation, 71 Avenue des Martyrs, CS 90181, 38042 Grenoble Cedex 9, France.
Virus Res. 2017 Apr 15;234:103-117. doi: 10.1016/j.virusres.2017.01.013. Epub 2017 Jan 20.
Influenza virus is a segmented, negative strand RNA virus with each genome segment being packaged in a distinct ribonucleoprotein particle (RNP). The RNP consists of the heterotrimeric viral RNA-dependent RNA polymerase bound to the conserved 5' and 3' ends of the genome segment (the viral promoter) with the rest of the viral RNA (vRNA) being covered by multiple copies of nucleoprotein. This review focusses on the new insights that recent crystal structures have given into the detailed molecular mechanisms by which the polymerase performs both transcription and replication of the vRNA genome. Promoter binding, in particular that of 5' end, is essential to allosterically activate all polymerase functions. Transcription is initiated by the hijacking of nascent, capped host transcripts by the process of 'cap-snatching', for which the viral polymerase makes an essential interaction with the C-terminal domain (CTD) of cellular RNA polymerase II. The structures allow a coherent mechanistic model of the subsequent cap-snatching, cap-dependent priming, elongation and self-polyadenylation steps of viral mRNA synthesis. During replication, the vRNA is copied without modification into complementary RNA (cRNA) which is packaged into cRNPs. A priming loop located in the polymerase active site is required for the unprimed synthesis of cRNA from vRNA, but is not required for cRNA to vRNA replication due to differences in the mode of initiation of RNA synthesis. Overall a picture emerges of influenza polymerase being a highly complex, flexible and dynamic machine. The challenge remains to understand in more detail how it functions within the RNP and how interacting host factors modulate its activity in the cellular context. Finally, these detailed insights have opened up new opportunities for structure-based antiviral drug design targeting multiple aspects of polymerase function.
流感病毒是一种分节段的负链RNA病毒,每个基因组节段被包装在一个独特的核糖核蛋白颗粒(RNP)中。RNP由异源三聚体病毒RNA依赖性RNA聚合酶组成,该聚合酶与基因组节段的保守5'和3'末端(病毒启动子)结合,其余的病毒RNA(vRNA)被多个核蛋白拷贝覆盖。本综述重点关注最近的晶体结构对聚合酶进行vRNA基因组转录和复制的详细分子机制所提供的新见解。启动子结合,特别是5'末端的结合,对于变构激活所有聚合酶功能至关重要。转录是通过“帽抢夺”过程劫持新生的、有帽的宿主转录本来启动的,为此病毒聚合酶与细胞RNA聚合酶II的C末端结构域(CTD)进行了关键的相互作用。这些结构为病毒mRNA合成随后的帽抢夺、帽依赖性引物合成、延伸和自我聚腺苷酸化步骤提供了一个连贯的机制模型。在复制过程中,vRNA未经修饰被复制成互补RNA(cRNA),cRNA被包装成cRNPs。位于聚合酶活性位点的引物环对于从vRNA无引物合成cRNA是必需的,但由于RNA合成起始模式的差异,cRNA到vRNA的复制不需要它。总体而言,流感病毒聚合酶呈现出一种高度复杂、灵活和动态的机器形象。挑战仍然是更详细地了解它在RNP内如何发挥作用,以及相互作用的宿主因子如何在细胞环境中调节其活性。最后,这些详细的见解为针对聚合酶功能多个方面的基于结构的抗病毒药物设计开辟了新机会。